Вioskin «Hyamatrix»is a bioplastic material, obtained as a result of the photochemical nano-structuring of the hyaluronic acid initial hydrocolloids.

produced by company «Nanosintes»

R.R. Rakhmatullin«Nanosintes» ltd.

Orenburg State University, Orenburg, Russia

Problem•4-5 burned per 1000 people. – 700 thousand people per annum* (for Russia). •20% of patients from burns units have deep burns that are critical or extracritical according to their area. •Mortality - 20-30%.•Trophic ulcers - 30% with noneffective traditional cure.

Treatment of burn patients is rather expensive and accompanied by the complex medical rehabilitation. For example, in the USA treatment of a patient with 40% burn of the total body area costs 180-200 thousand dollars, in Israel — 90-100 thousand dollars. Every year millions of people are heavily burned. The use of artificial skin substitutes makes it possible to restore wounded skin surface faster.

The World Best Analogues

• HYAFF

• OrCel -matrix

• Apligraf

• Graftskin

Nanopatterned biopolymer of the hyaluronic acid native form

Solution

«HYAFF» «Hyamatrix»

Price

Special conditions

$135.

Bandaging – soreness

$45-50.

Doesn’t require bandaging – no

soreness

Competitors and our advantages

Market

Market capacity (the USA, Europe) – $3 billion per annum*

From 2000г. – wanton growth (over15% per annum)*.

Market assessment - $40-50 million per annum. Potential rate of growth is over 30% per annum*.

* «Farmexpert» data (2000, 2008гг.)

Monetization Model

•Bioskin «Hyamatrix» ultimate customers – patients with noneffective traditional cure, including using competitive biomaterials.

•Market share - 3% •With growth trend – 5% per annum.

New biomaterial will be applied in:

1.Burn centers. Hospital procurement, wholesale.

2. Medical institutions of surgical profile.

Hospital procurement, wholesale.

3. Cosmetic institutions and beauty salons. wholesale and retail.

Promoting Methods.Strategic partner with distribution network.

Stage of a projectInitial and early growth – drug product

manufacture and sale organization

INDICATORS 

01.01.2012annual 

balance, $

1The financial resources of the enterprise from internal and external sources, total, including: 820.000

1.1 Revenues from sales 400.000

1.2 Funds of the company promoters 100.000

1.3Funds from other sourcesOrenburg region Guarantee Fund 20.000

1.4 Contracted amount for 2013 (Russian Federation, Kazakhstan) 300.000

Stage of a project

INDICATORS $ 

Expenses on a production site. 2.500.000

Documentation, GMP, documentation registration on production 50.000

Advertizing, marketing 450.0000

Total: 3.000.000

Investments – $3 million

Thank you, for yours kind attention

«Nanosintez» Research and Development Enterprise 

LLC 13 Pobeda prospect, Orenburg, Russia, 460000

Phone: +7 495-646-61-01

www.hyamatrix.ruContact person:

Rahmatullin Ramil+7 912 846 7203